medigraphic.com

2001, Number 4

<< Back Next >>

Rev Fac Med UNAM 2001; 44 (4)

Multiple organic failure mortality in a ICU

Carrillo ER, Téllez MMA, Salinas RS

Language: Spanish
References: 25
Page: 156-160
PDF size: 56.22 Kb.


ABSTRACT

Objective: Study the mortality for multiple organic dysfunction in an Intensive Care Unit. A retrospective files study.
Results: Out of 43 patients with this syndrome during one year 19 died and 24 survived. Those that survived presented less than two organ failures, and they could be reverted. Those who died presented two or more failures that didn’t revert.
The risk factors for multiple organic dysfunction in this group were: age more 70 years, intensity of the damage, shock, multiple transfusions, sepsis and major surgery. Mortality increase as soon as the organs were involved.
Patients with two organs failing had a mortality of 21%, with three failures it raised to 68% and mounted to 100% when four organs or systems failed.
Conclusion: The syndrome of multiple organic dysfunction is a complex phenomenon whose evolution is determined by the dynamic interaction of a chain of events and the answer of the host to the first stimulus. It has not been determined if the final evolution reflects the variable expression of a single pathogenic process or it is due to several biological processes.


REFERENCES

  1. Xiandong Wang. The Role of Endothelial Cells in the Systemic Inflammatory Response Syndrome and Multiple System Organ Failure. Eur J Surg 1995; 161: 703-713

  2. Bone RC, M.D. Immunologic Dissonance: A continuing Evolution Our Understanding in the Systemic Inflammatory Response Syndrome (SIRS) and Multiple Organ Dysfunction Syndrome (MODS). Ann Intern Med. 1996; 125: 680-687.

  3. Baue AE, MD. Multiple Organ Failure, Multiple Organ Dysfunction Syndrome, and Systemic Inflammatory Response Syndrome. Arch Surg 1997; 132: 703-707.

  4. Bone RC, MD, Charles J. Grodzin MD. Sepsis: A new Hypothesis for Pathogenesis of the Disease Process. Chest 1997; 112: 235-243.

  5. Pastor CM, MD and Suter P. Hepatic Hemodynamics and Cell Functions in Humans and Experimental Sepsis. Anesth Analg 1999; 89: 344-52.

  6. Satoshi Gando, MD, Takashi Kameue, MD. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med 25: 1820-1826.

  7. Salvo A. Wolfer, Montani C. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995; 21: S244-S249.

  8. Marietta J, Bertleff O and Hajo. Briuning. How should multiple organ dysfunction syndrome be assessed? A review of the variations in current scoring systems. Eur J Surg 1997; 163: 405-409.

  9. Sydney Jacobs MB, Mehrun Zuleika MB. The multiple organ dysfunction score as a descriptor of patient outcome in septic shock compared with two other scoring systems. Cri Care Med 1999; 27: 741-744.

  10. Evans TW, Smithies M. ABC of intensive care. Organ dysfunction. BMJ 1999; 138: 1606-1608.

  11. Members of the American College of Chest physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for Sepsis and Organ Failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.

  12. MICU, St. Vincent Hospital, University of Massachusetts Medical School. The hemodinamic deragements in Sepsis. Chest 1998; 114: 854-861.

  13. Yoshio Haga MD, Toru Beppu MD. Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Critical Care Med 1997; 25: 1994-2000.

  14. Balk RA, MD. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Critical Care Clinics 2000; 16(2).

  15. Garrison N, MD, Spain DA, MD, Microvascular Changes explain the “ Two-Hit” theory of multiple organ failure. Annals of Surgery 1998; 227: 851-860.

  16. Crouser ED, MD, Dorinsky PM, MD. Metabolic consequences of sepsis. Clinics Chest Medicine; 17: 249-261.

  17. Anad Kumar MD. Inotropes and gut mucosal perfusión: A brake on the motor of multiple organ failure. Critical Care Medicine; 25: 166-167.

  18. Kirton O, MD. Windsor J, MD. Failure of splachnic in the acutely injured trauma patient correlates with multiple organ system failure and length of stay in the UCI. Clinics in Chest Medicine 1996; 17(2): 249-51.

  19. Deitch E, Goodman E, MD. Prevention of multiple organ failure. Surgical Clinics of Norteamerica. 1999; 79(6).

  20. Borrelli E, MD, Roux LP, MD. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Critical Care Medicine 1996; 24: 391-397.

  21. Rangel F, MD, Pittet Didier MD. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995; 273: 117-123.

  22. Gomersall Charles, Gavin Joint. Resuscitation of critically ill patients based on the results of gastric tonometry: a prospective study, randomized, controlled trial. Critical Care Medicine 2000; 28: 607-614.

  23. Slutzky AS, Liu M. Antiinflamatory therapies: application of molecular biology techniques in intensive care medicine. Intensive Care Med 1997; 23: 718-731.

  24. Deutschman Cliford MS, MD. Acute phase response and SIRS/MODS: the good, the bad, and the nebulous. Critical Care Medicine 1998; 26: 630-632.

  25. McCarty S, Katz D. Splachnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. American Journal of Gastroenterology 1996; 91: 1697-1710.




2020     |     www.medigraphic.com